Atika Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-48,000
Closed -$3.27M 84
2024
Q1
$3.27M Buy
+48,000
New +$3.27M 0.32% 70
2020
Q4
Hold
0
95
2020
Q3
Hold
0
94
2018
Q4
Hold
0
56
2018
Q3
Sell
-52,000
Closed -$3.06M 78
2018
Q2
$3.06M Buy
+52,000
New +$3.06M 0.59% 52